SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-043471
Filing Date
2019-07-29
Accepted
2019-07-29 16:09:47
Documents
2
Period of Report
2019-07-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1545
2 POA DOCUMENT poa.txt EX-24.3_866265 4231
  Complete submission text file 0001209191-19-043471.txt   7265
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Unum Therapeutics Inc. (Issuer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EPIZYME, INC. 400 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address
Ros Matthew (Reporting) CIK: 0001673802 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38443 | Film No.: 19981279